AUTHOR + STRATEGIST

SergeyVlasenko, Ph.D.

A life-sciences and diagnostics strategy executive writing about the systems that turn scientific possibility into durable categories, businesses, and markets.

THE PERSPECTIVE

Writing from inside the handoffs.

Sergey’s career spans diagnostics, life-science tools, and biopharma—across analytical infrastructure, platform commercialization, business development, corporate strategy, and global innovation partnerships.

His books examine the places where elegant science meets institutional reality: the handoffs between technology and workflow, proof and trust, invention and procurement, product and operating system, discovery and strategic control.

EXPERIENCE IN CONTEXT

Built across science, strategy, and operations.

BIO-RAD

Building biopharma businesses

Commercial and strategic leadership in life-science tools and biopharma.

PROZYME

Leading through an exit

CEO of a specialized life-science tools company acquired by Agilent.

AGILENT

Enterprise market strategy

Senior leadership across global pharma and biopharma end markets.

FAPON

Strategy across ecosystems

Strategy and partnership work linking diagnostics, platforms, and global innovation.

THE THREE-BOOK SERIES

Follow the category from formation to control.

Find the books